Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes.
Lahu S, Ndrepepa G, Gewalt S, Schüpke S, Pellegrini C, Bernlochner I, Aytekin A, Neumann FJ, Menichelli M, Richardt G, Cassese S, Xhepa E, Kufner S, Sager HB, Joner M, Ibrahim T, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A, Mayer K. Lahu S, et al. Among authors: fusaro m. Int J Cardiol. 2021 Sep 1;338:8-13. doi: 10.1016/j.ijcard.2021.06.011. Epub 2021 Jun 11. Int J Cardiol. 2021. PMID: 34126130 Clinical Trial.
Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial.
Byrne RA, Kastrati A, Kufner S, Massberg S, Birkmeier KA, Laugwitz KL, Schulz S, Pache J, Fusaro M, Seyfarth M, Schömig A, Mehilli J; Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Investigators. Byrne RA, et al. Among authors: fusaro m. Eur Heart J. 2009 Oct;30(20):2441-9. doi: 10.1093/eurheartj/ehp352. Epub 2009 Aug 30. Eur Heart J. 2009. PMID: 19720642 Clinical Trial.
Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis.
Kufner S, Hausleiter J, Ndrepepa G, Schulz S, Bruskina O, Byrne RA, Fusaro M, Kastrati A, Schömig A, Mehilli J; OSIRIS Trial Investigators. Kufner S, et al. Among authors: fusaro m. JACC Cardiovasc Interv. 2009 Nov;2(11):1142-8. doi: 10.1016/j.jcin.2009.08.015. JACC Cardiovasc Interv. 2009. PMID: 19926058 Free article. Clinical Trial.
Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention.
Ndrepepa G, Mehilli J, Tiroch K, Fusaro M, Kufner S, Ellert J, Goedel J, Schömig A, Kastrati A. Ndrepepa G, et al. Among authors: fusaro m. Rev Esp Cardiol. 2010 Jul;63(7):770-8. doi: 10.1016/s1885-5857(10)70161-4. Rev Esp Cardiol. 2010. PMID: 20609310 Free article. English, Spanish.
Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
Kufner S, Massberg S, Dommasch M, Byrne RA, Tiroch K, Ranftl S, Fusaro M, Schömig A, Kastrati A, Mehilli J; Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents Trial Investigators. Kufner S, et al. Among authors: fusaro m. Catheter Cardiovasc Interv. 2011 Aug 1;78(2):161-6. doi: 10.1002/ccd.22823. Epub 2011 Mar 11. Catheter Cardiovasc Interv. 2011. PMID: 21400652 Clinical Trial.
Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina.
Ndrepepa G, Braun S, Schulz S, Fusaro M, Keta D, Pache J, Seyfarth M, Mehilli J, Schömig A, Kastrati A. Ndrepepa G, et al. Among authors: fusaro m. Eur J Clin Invest. 2011 Oct;41(10):1054-62. doi: 10.1111/j.1365-2362.2011.02500.x. Epub 2011 Mar 17. Eur J Clin Invest. 2011. PMID: 21413976
373 results